GOJITECH
LIVE

Serial Number

79444788

Owner

Goji Technology Systems Inc.

Filing Date

Dec 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GOJITECH Trademark

Serial Number: 79444788

GOJITECH is a trademark filed by Goji Technology Systems Inc. on December 22, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Goji Technology Systems Inc. (4 trademarks)

53 Parkside Drive

Entity Type: 03

Trademark Details

Filing Date

December 22, 2025

Registration Date

Not Registered

Goods & Services

Providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for accessing, browsing and searching databases containing clinical research data in the field of cannabinoid-based pharmaceuticals and therapy; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for administering insurance coverage; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for customized searching and filtering of catalogs and formularies of the pharmaceutical products of others; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for managing insurance policies; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for processing insurance claims; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for providing information about cannabinoid-based pharmaceuticals and therapy; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for providing information about insurance policies and rates; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for searching structured and unstructured data for healthcare analytics; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for the management and electronic delivery of insurance documents and insurance claims information; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for use in customer relationship management (CRM); providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for use in the analysis and evaluation of the products of others to assure compliance with industry standards; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) to allow users to track and analyze consumer consumption of cannabinoid-based pharmaceuticals for medical purposes; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) to automate workflows in the field of healthcare; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for facilitating the interoperability and secure exchange of healthcare information; providing non-downloadable artificial intelligence software, computer software, platform as a service (PaaS), and software as a service (SaaS) for digital health analytics; cannabinoid product evaluation; data automation and collection of clinical data from pharmacy-led patient care programs to support evaluation, analysis, and research; data automation and data collection using software to evaluate, analyze, collect clinical research data in the field of cannabinoid-based pharmaceuticals and therapy; providing medical and scientific research information in the field of cannabinoid-based pharmaceuticals and therapy.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 6, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 5, 2026 CNRT
ASSIGNED TO EXAMINER
May 4, 2026 DOCK
ASSIGNED TO EXAMINER
Apr 28, 2026 DOCK
ASSIGNED TO EXAMINER
Apr 23, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 26, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 26, 2026 REPR